1 documents found
Information × Registration Number 0107U012639, R & D request Title Double, blind, placebo-controlled, multicentered 52 -week investigation Phase III held in parallel groups for efficacy and safety evaluation of two regimens dosage of dried CDP 870 injected subcutaneously as supplement to the therapy with Metodrexat in treatment of symptoms and prevention of structural damage in patients with active rheumatoid arthritis in insufficient effect of Metodrexat Report # CDP870-027 Head Лисенко Григорій Іванович, Registration Date 27-12-2007 Organization Shupyk National Medical Academy of Postgraduate Education popup.description1 popup.nrat_date 2024-12-10 Close
search.res_rk
Double, blind, placebo-controlled, multicentered 52 -week investigation Phase III held in parallel groups for efficacy and safety evaluation of two regimens dosage of dried CDP 870 injected subcutaneously as supplement to the therapy with Metodrexat in treatment of symptoms and prevention of structural damage in patients with active rheumatoid arthritis in insufficient effect of Metodrexat Report # CDP870-027
Head: Лисенко Григорій Іванович. Double, blind, placebo-controlled, multicentered 52 -week investigation Phase III held in parallel groups for efficacy and safety evaluation of two regimens dosage of dried CDP 870 injected subcutaneously as supplement to the therapy with Metodrexat in treatment of symptoms and prevention of structural damage in patients with active rheumatoid arthritis in insufficient effect of Metodrexat Report # CDP870-027. Shupyk National Medical Academy of Postgraduate Education. № 0107U012639
1 documents found

Updated: 2026-03-22


Роздрукувати цю сторінку